Yoshiyuki Suehara Selected Research

Yoshiyuki Suehara Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 01/2004
11	Sarcoma (Soft Tissue Sarcoma) 04/2021 - 08/2006
10	Neoplasm Metastasis (Metastasis) 03/2021 - 05/2011
9	Adenocarcinoma of Lung 03/2022 - 12/2012
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2018 - 03/2008
5	Osteosarcoma (Osteogenic Sarcoma) 11/2019 - 09/2008
4	Lung Neoplasms (Lung Cancer) 03/2022 - 09/2014
4	Leiomyosarcoma 04/2021 - 08/2006
4	Microsatellite Instability 01/2021 - 01/2017
4	Giant Cell Tumors (Giant Cell Tumor) 01/2019 - 10/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 11/2019
2	Desmoplastic Small Round Cell Tumor 01/2022 - 04/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2021 - 03/2018
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2021 - 06/2021
2	Neurofibrosarcoma (MPNST) 04/2021 - 09/2008
2	Carcinogenesis 01/2021 - 11/2016
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2016
2	Adenocarcinoma 09/2020 - 01/2018
2	Alveolar Soft Part Sarcoma 01/2017 - 10/2016
2	Desmoplastic Fibroma 05/2014 - 01/2013
2	Synovial Sarcoma (Synovioma) 05/2011 - 09/2008
1	Lymphatic Metastasis 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2020
1	Giant Cell Tumor of Bone 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Turcot syndrome 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 10/2016
1	Rheumatoid Arthritis 10/2016
1	Ulcer 07/2016

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2006
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
7	Phosphotransferases (Kinase)IBA 10/2021 - 05/2014
7	Tyrosine Kinase InhibitorsIBA 10/2021 - 09/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2014
4	Denosumab FDA Link 01/2020 - 12/2014
4	Formaldehyde (Formol)FDA Link 12/2019 - 06/2013
4	ParaffinIBA 12/2019 - 06/2013
3	RNA (Ribonucleic Acid)IBA 10/2021 - 05/2014
3	Protein Isoforms (Isoforms)IBA 07/2021 - 08/2006
3	Messenger RNA (mRNA)IBA 04/2021 - 12/2012
3	Tyrosine (L-Tyrosine)FDA Link 04/2021 - 03/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2021 - 12/2012
3	Immune Checkpoint InhibitorsIBA 03/2021 - 10/2016
3	Gefitinib (Iressa)FDA Link 11/2019 - 01/2015
3	TropomyosinIBA 10/2019 - 08/2006
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016 - 01/2015
3	CollagenIBA 01/2015 - 01/2013
2	larotrectinibIBA 11/2021 - 10/2019
2	Thyroid Nuclear Factor 1IBA 07/2021 - 06/2021
2	Pharmaceutical PreparationsIBA 04/2021 - 10/2016
2	MucinsIBA 03/2021 - 01/2021
2	tyrosine receptor (receptor, tyrosine)IBA 11/2020 - 05/2014
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2020 - 03/2015
2	GlypicansIBA 09/2020 - 01/2018
2	Transcription Factor 4IBA 11/2019 - 01/2018
2	cabozantinibIBA 01/2017 - 06/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2016 - 05/2014
2	Monoclonal AntibodiesIBA 06/2013 - 01/2010
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	AfatinibIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	B7-H1 AntigenIBA 11/2021
1	entrectinibIBA 11/2021
1	Carcinoembryonic AntigenIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Immunoglobulins (Immunoglobulin)IBA 03/2021
1	phosphatidyl-N-monomethylaminoethanolIBA 01/2021
1	pazopanib FDA Link 11/2020
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2020
1	nintedanibIBA 07/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2020
1	osimertinibIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	NucleotidesIBA 04/2019
1	pembrolizumabIBA 02/2019
1	Fetal Proteins (Fetoprotein)IBA 01/2018
1	GlycogenIBA 01/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	PENTAIBA 01/2017
1	PromegaIBA 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2016
1	Arginine (L-Arginine)FDA Link 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2016
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 10/2016
1	AntibodiesIBA 10/2016
1	NivolumabIBA 10/2016
1	Bevacizumab (Avastin)FDA Link 07/2016

Therapy/Procedure

19	Therapeutics 10/2021 - 08/2006
7	Drug Therapy (Chemotherapy) 10/2021 - 04/2004
3	Immunotherapy 01/2022 - 03/2021
3	Precision Medicine 06/2021 - 04/2019
3	Curettage 01/2020 - 10/2011
2	Radiotherapy 01/2021 - 11/2020
1	Transplantation 01/2021